Cyclin-Dependent Kinase 4 and 6 Inhibitors in Breast Cancer Treatment

The authors systematically discussed the mechanisms of resistance to CDK4/6 inhibitors including the cell cycle-specific and cell cycle-nonspecific mechanisms.